Expression analyses of the mitochondrial complex i 75-kDa subunit in early onset schizophrenia and autism spectrum disorder: Increased levels as a potential biomarker for early onset schizophrenia

European Child and Adolescent Psychiatry

Volumn 19, Issue 5, 2010, Pages 441-448

  Taurines, Regina ^a   Thome, Johannes ^b   Duvigneau, J Catharina ^c   Forbes Robertson, Sarah ^b   Yang, Liya ^b   Klampfl, Karin ^a   Romanos, Jasmin ^a   Müller, Sabine ^d   Gerlach, Manfred ^a   Mehler Wex, Claudia ^d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF WALES   (United Kingdom)

^c UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

75 kDa subunit; Autistic spectrum disorder; Biological marker; Early onset schizophrenia; Mitochondrial complex I

Indexed keywords

AMPHETAMINE; ATOMOXETINE; FLUOXETINE; LITHIUM ACETATE; MESSENGER RNA; METHYLPHENIDATE; PROTEIN SUBUNIT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); RISPERIDONE; SERTRALINE; TIAPRIDE;

ADOLESCENT; ARTICLE; AUTISM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISORDERS OF MITOCHONDRIAL FUNCTIONS; FEMALE; HUMAN; MALE; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PROTEIN EXPRESSION; SCHIZOPHRENIA;

ADOLESCENT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; ELECTRON TRANSPORT COMPLEX I; FEMALE; GENE EXPRESSION; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 77953649826     PISSN: 10188827     EISSN: 1435165X     Source Type: Journal    
DOI: 10.1007/s00787-009-0074-z     Document Type: Article

References (51)

1. D Ben-Shachar R Zuk H Gazawi A Reshef A Sheinkman E Klein 1999 Increased mitochondrial complex I activity in platelets of schizophrenic patients Int J Neuropsychopharmacol 2 245 253 10.1017/S1461145799001649 1:CAS:528: DC%2BD3cXnsVKksA%3D%3D 11285140
2. D Ben-Shachar O Bonne R Chisin E Klein H Lester J Aharon-Peretz I Yona N Freedman 2007 Cerebral glucose utilization and platelet mitochondrial complex I activity in schizophrenia: a FDG-PET study Prog Neuropsychopharmacol Biol Psychiatry 31 807 813 10.1016/j.pnpbp.2006.12.025 1:CAS:528:DC%2BD2sXkvFGksL0%3D 17329000 (Pubitemid 46671478)
3. D Ben-Shachar R Karry 2007 Sp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2 PLoS One 2 e817 10.1371/journal.pone.0000817 17786189 (Pubitemid 351420081)
4. N Dror E Klein R Karry A Sheinkman Z Kirsh M Mazor 2002 State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia Mol Psychiatry 7 995 1001 10.1038/sj.mp.4001116 1:CAS:528:DC%2BD38XotFWrsrc%3D 12399953 (Pubitemid 35333055)
5. R Karry E Klein D Ben-Shachar 2004 Mitochondrial complex I subunits expression is altered in schizophrenia: a postmortem study Biol Psychiatry 55 676 684 10.1016/j.biopsych.2003.12.012 1:CAS:528:DC%2BD2cXisVegsrg%3D 15038995 (Pubitemid 38376178)
6. D Ben-Shachar 2002 Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine J Neurochem 83 1241 1251 10.1046/j.1471-4159.2002.01263.x 1:CAS:528:DC%2BD3sXjsFGr 12472879 (Pubitemid 35477464)
7. D Ben-Shachar D Laifenfeld 2004 Mitochondria, synaptic plasticity, and schizophrenia Int Rev Neurobiol 59 273 296 10.1016/S0074-7742(04)59011-6 1:CAS:528:DC%2BD2cXktVertLk%3D 15006492 (Pubitemid 39752419)
8. MS Buchsbaum 1990 The frontal lobes, basal ganglia, and temporal lobes as sites for schizophrenia Schizophr Bull 16 379 389 1:STN:280: DyaK3M7kt1OntA%3D%3D 2287929
9. MS Buchsbaum KH Nuechterlein RJ Haier J Wu N Sicotte E Hazlett R Asarnow S Potkin S Guich 1990 Glucose metabolic rate in normals and schizophrenics during the continuous performance test assessed by positron emission tomography Br J Psychiatry 156 216 227 10.1192/bjp.156.2.216 1:STN:280:DyaK3c7pvFeluw%3D%3D 2317626
10. MS Buchsbaum BR Buchsbaum EA Hazlett MM Haznedar R Newmark CY Tang PR Hof 2007 Relative glucose metabolic rate higher in white matter in patients with schizophrenia Am J Psychiatry 164 1072 1081 10.1176/appi.ajp.164.7.1072 17606659 (Pubitemid 47121396)
11. RM Cohen WE Semple M Gross TE Nordahl AC King D Pickar RM Post 1989 Evidence for common alterations in cerebral glucose metabolism in major affective disorders and schizophrenia Neuropsychopharmacology 2 241 254 10.1016/0893-133X(89)90028-6 1:CAS:528:DyaK3cXktVCju74%3D 2610821 (Pubitemid 20025251)
12. RE Gur PD Mozley SM Resnick LH Mozley DL Shtasel F Gallacher SE Arnold JS Karp A Alavi M Reivich, et al. 1995 Resting cerebral glucose metabolism in first-episode and previously treated patients with schizophrenia relates to clinical features Arch Gen Psychiatry 52 657 667 1:CAS:528:DyaK2MXnsFeju78%3D 7632119
13. EA Hazlett MS Buchsbaum MM Haznedar MB Singer MK Germans DB Schnur EA Jimenez BR Buchsbaum BT Troyer 1998 Prefrontal cortex glucose metabolism and startle eyeblink modification abnormalities in unmedicated schizophrenia patients Psychophysiology 35 186 198 10.1017/S0048577298001863 1:STN:280:DyaK1c7ptVymsg%3D%3D 9529945 (Pubitemid 28113703)
14. EA Hazlett MS Buchsbaum E Kemether R Bloom J Platholi AM Brickman L Shihabuddin C Tang W Byne 2004 Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia Am J Psychiatry 161 305 314 10.1176/appi.ajp.161.2.305 14754780 (Pubitemid 38419282)
15. MM Haznedar MS Buchsbaum EA Hazlett L Shihabuddin A New LJ Siever 2004 Cingulate gyrus volume and metabolism in the schizophrenia spectrum Schizophr Res 71 249 262 10.1016/j.schres.2004.02.025 15474896 (Pubitemid 39330503)
16. K Iwamoto M Bundo T Kato 2005 Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis Hum Mol Genet 14 241 253 10.1093/hmg/ddi022 1:CAS:528:DC%2BD2MXitFGksw%3D%3D 15563509
17. FA Middleton K Mirnics JN Pierri DA Lewis P Levitt 2002 Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia J Neurosci 22 2718 2729 1:CAS:528:DC%2BD38XisF2ntb8%3D 11923437
18. S Prabakaran JE Swatton MM Ryan SJ Huffaker JT Huang JL Griffin M Wayland T Freeman F Dudbridge KS Lilley NA Karp, et al. 2004 Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress Mol Psychiatry 9 684 697 10.1038/sj.mp.4001532 1:CAS:528:DC%2BD2cXltFWntLs%3D 15098003 643 (Pubitemid 38932169)
19. C Mehler-Wex JC Duvigneau RT Hartl D Ben-Shachar A Warnke M Gerlach 2006 Increased mRNA levels of the mitochondrial complex I 75-kDa subunit. A potential peripheral marker of early onset schizophrenia? Eur Child Adolesc Psychiatry 15 504 507 10.1007/s00787-006-0560-5 16788776 (Pubitemid 46020536)
20. N Durany J Thome 2004 Neurotrophic factors and the pathophysiology of schizophrenic psychoses Eur Psychiatry 19 326 337 10.1016/j.eurpsy.2004.06.020 15363470 (Pubitemid 39207958)
21. JL Rapoport AM Addington S Frangou MR Psych 2005 The neurodevelopmental model of schizophrenia: update Mol Psychiatry 10 434 449 10.1038/sj.mp.4001642 1:CAS:528:DC%2BD2MXkt1Wksrk%3D 15700048 (Pubitemid 40646432)
22. DH Geschwind P Levitt 2007 Autism spectrum disorders: developmental disconnection syndromes Curr Opin Neurobiol 17 103 111 10.1016/j.conb.2007.01. 009 1:CAS:528:DC%2BD2sXhvVOqtLo%3D 17275283 (Pubitemid 46237744)
23. SJ Palmen H van Engeland PR Hof C Schmitz 2004 Neuropathological findings in autism Brain 127 2572 2583 10.1093/brain/awh287 15329353 (Pubitemid 39627367)
24. F Polleux JM Lauder 2004 Toward a developmental neurobiology of autism Ment Retard Dev Disabil Res Rev 10 303 317 10.1002/mrdd.20044 15666334 (Pubitemid 40209463)
25. A Chauhan V Chauhan WT Brown I Cohen 2004 Oxidative stress in autism: increased lipid peroxidation and reduced serum levels of ceruloplasmin and transferrin-the antioxidant proteins Life Sci 75 2539 2549 10.1016/j.lfs.2004. 04.038 1:CAS:528:DC%2BD2cXnsFSqtr8%3D 15363659 (Pubitemid 39195260)
26. PA Filipek J Juranek M Smith LZ Mays ER Ramos M Bocian D Masser-Frye TM Laulhere C Modahl MA Spence JJ Gargus 2003 Mitochondrial dysfunction in autistic patients with 15q inverted duplication Ann Neurol 53 801 804 10.1002/ana.10596 1:CAS:528:DC%2BD3sXkslGhsL4%3D 12783428 (Pubitemid 36622519)
27. JJ Fillano MJ Goldenthal CH Rhodes J Marín-García 2002 Mitochondrial dysfunction in patients with hypotonia, epilepsy, autism, and developmental delay: HEADD syndrome J Child Neurol 17 435 439 10.1177/088307380201700607 12174964
28. WD Graf J Marin-Garcia HG Gao S Pizzo RK Naviaux D Markusic BA Barshop E Courchesne RH Haas 2000 Autism associated with the mitochondrial DNA G8363A transfer RNA(Lys) mutation J Child Neurol 15 357 361 10.1177/088307380001500601 1:STN:280:DC%2BD3cvps1emtA%3D%3D 10868777
29. R Pons AL Andreu N Checcarelli MR Vilà K Engelstad CM Sue D Shungu R Haggerty DC de Vivo S DiMauro 2004 Mitochondrial DNA abnormalities and autistic spectrum disorders J Pediatr 144 81 85 10.1016/j.jpeds.2003.10.023 1:CAS:528:DC%2BD2cXosFyi 14722523 (Pubitemid 38091426)
30. S Sögüt SS Zoroglu H Ozyurt HR Yilmaz F Ozugurlu E Sivasli O Yetkin M Yanik H Tutkun HA Savas M Tarakçioglu O Akyol 2003 Changes in nitric oxide levels and antioxidant enzyme activities may have a role in the pathophysiological mechanisms involved in autism Clin Chim Acta 331 111 117 10.1016/S0009-8981(03)00119-0 12691871 (Pubitemid 36412032)
31. TM Achenbach CS Edelbrock 1981 Behavioural problems and competencies reported by parents of normal and disturbed children aged four through sixteen Monogr Soc Res Child Dev 46 1 82 10.2307/1165983 1:STN:280:DyaL3M3itVKrtw%3D%3D 7242540
32. JE Overall DR Gorham 1962 The brief psychiatric rating scale Psychol Rep 10 799 812 10.2466/PR0.10.3.799-812
33. Rutter M, Bailey A, Berument SK, Le Couteur A, Lord C, Pickles A (2003) Social communication questionnaire (SCQ). Western Psychological Services, Los Angeles
34. Bolte S, Poustka F (2006) FSK-Fragebogen zur Sozialen Kommunikation. Huber, Bern
35. C Lord M Rutter A Le Couteur 1994 Autism diagnostic interview-revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders J Autism Dev Disord 24 659 685 10.1007/BF02172145 1:STN:280:DyaK2M7htlOlsg%3D%3D 7814313 (Pubitemid 24309810)
36. Bolte S, Rühl D, Schmötzer G, Poustka F (2006) ADI-R. Diagnostisches Interview für Autismus-Revidiert. Huber, Bern
37. C Lord M Rutter S Goode J Hemsbergen H Jordan L Mawhood E Schopler 1989 Autism Diagnostic Observation Schedule: a standardized observation of communicative and social behavior J Autism Dev Disord 19 185 212 10.1007/BF02211841 1:STN:280:DyaL1MzgvVGisw%3D%3D 2745388
38. C Lord S Risi L Lambrecht EH Cook Jr BL Leventhal PC DiLavore A Pickles M Rutter 2000 The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism J Autism Dev Disord 30 205 223 10.1023/A:1005592401947 1:STN:280:DC%2BD3crgsVOktA%3D%3D 11055457
39. Ruehl D, Bolte S, Feineis-Matthews S, Poustka F (2004) ADOS-Diagnostische Beobachtungsskala fuer Autistische Stoerungen. Huber, Bern
40. PF Sullivan C Fan CM Perou 2006 Evaluating the comparability of gene expression in blood and brain Am J Med Genet B Neuropsychiatr Genet 141B 261 268 10.1002/ajmg.b.30272 16526044
41. S Washizuka M Kametani T Sasaki M Tochigi T Umekage K Kohda T Kato 2006 Association of mitochondrial complex I subunit gene NDUFV2 at 18p11 with schizophrenia in the Japanese population Am J Med Genet B Neuropsychiatr Genet 141B 301 304 10.1002/ajmg.b.30285 1:CAS:528:DC%2BD2sXmsFalsL4%3D 16508936
42. AO Fagundes GT Rezin F Zanette E Grandi LC Assis F Dal-Pizzol J Quevedo EL Streck 2007 Chronic administration of methylphenidate activates mitochondrial respiratory chain in brain of young rats Int J Dev Neurosci 25 47 51 10.1016/j.ijdevneu.2006.11.001 1:CAS:528:DC%2BD2sXht1Oksb4%3D 17188451 (Pubitemid 46162062)
43. BN Frey SS Valvassori KM Gomes MR Martins F Dal-Pizzol F Kapczinski J Quevedo 2006 Increased oxidative stress in submitochondrial particles after chronic amphetamine exposure Brain Res 1097 1 224 229 10.1016/j.brainres.2006. 04.076 1:CAS:528:DC%2BD28XmslGhtLY%3D 16730669 (Pubitemid 44041287)
44. J Casademont G Garrabou O Miró S López A Pons M Bernardo F Cardellach 2007 Neuroleptic treatment effect on mitochondrial electron transport chain: peripheral blood mononuclear cells analysis in psychotic patients Clin Psychopharmacol 27 284 288 10.1097/JCP.0b013e318054753e 1:CAS:528: DC%2BD2sXlt1Cgsbk%3D (Pubitemid 46763311)
45. C Burkhardt JP Kelly YH Lim CM Filley WD Parker 1993 Neuroleptic medications inhibit complex I of the electron transport chain Ann Neurol 33 512 517 10.1002/ana.410330516 1:CAS:528:DyaK3sXlvFGnu70%3D 8098932
46. I Maurer HJ Moller 1997 Inhibition of complex I by neuroleptics in normal human brain cortex paralles the extrapyramidal toxicity of neuroleptics Mol Cell Biochem 174 255 259 10.1023/A:1006872911332 1:CAS:528:DyaK2sXmt1equ7w%3D 9309697 (Pubitemid 27404200)
47. A Barrientos C Marin O Miro J Casademont M Gomez V Nunes E Tolosa A Urbano-Marquez F Cardellach 1998 Biochemical and molecular effects of chronic haloperidol administration on brain and muscle mitochondria of rats J Neurosci Res 53 475 481 10.1002/(SICI)1097-4547(19980815)53:4<475::AID-JNR9>3.0. CO;2-3 1:CAS:528:DyaK1cXltVegsr8%3D 9710267 (Pubitemid 28363209)
48. JA Prince MS Yassin L Oreland 1997 Neuroleptic-induced mitochondrial enzyme alterations in the rat brain J Pharmacol Exp Ther 280 261 267 1:CAS:528:DyaK2sXntFaqtg%3D%3D 8996205
49. SA Whatley D Curi RM Marchbanks 1996 Mitochondrial involvement in schizophrenia and other functional psychoses Neurochem Res 21 995 1004 10.1007/BF02532409 1:CAS:528:DyaK28Xmt12hu7g%3D 8897462 (Pubitemid 26349764)
50. SA Whatley D Curi F Das Gupta IN Ferrier S Jones C Taylor RM Marchbanks 1998 Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients Mol Psychiatry 3 227 237 10.1038/sj.mp.4000375 1:CAS:528:DC%2BD3cXlslegs78%3D 9672898
51. JK Yao RD Reddy DP van Kammen 2001 Oxidative damage and schizophrenia. An overview of the evidence and its therapeutic implications CNS Drugs 15 287 310 10.2165/00023210-200115040-00004 1:CAS:528:DC%2BD3MXjs12nsb0%3D 11463134